首页 > 市场调查报告书 > 製药

眼科药物

市场调查报告书

商品编码

1477244

全球妥布霉素眼药水市场，按类型、适应症、配销通路和地理位置

Global Tobramycin Eye Drop Market, By Type, By Indication, By Distribution Channel, and Geography

出版日期: 2024年04月24日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球妥布霉素眼药水市值为10.189亿美元，预计2031年将达到25.732亿美元，2024年至2031年的年复合成长率（CAGR）为14.1%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	10.189 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	14.10%	2031 年价值预测：	25.732 亿美元

数字。 2024 年全球妥布霉素眼药水市场占有率 (%)，依地区划分

妥布霉素眼药水是外用氨基糖苷类抗生素，用于治疗敏感革兰氏阴性菌引起的外眼感染。这些药物透过干扰细菌蛋白质合成来发挥作用，从而阻止有害细菌的生长。由于长时间使用电脑、配戴隐形眼镜、眼科手术等危险因子的增加，全球眼部感染的盛行率不断上升，增加了对妥布霉素眼药水的需求。

市场动态：

由于眼部疾病盛行率上升、更容易出现眼部问题的老年人口增加以及人们对眼睛护理意识的提高等因素，全球妥布霉素眼药水市场一直在成长。然而，由于长期使用妥布霉素眼药水带来的副作用（如眼睛刺激、结膜炎等）等因素，市场成长可能会受到阻碍。使用妥布霉素的新型药物输送方法和联合疗法的持续研究和开发为市场参与者提供了利润丰厚的机会。

研究的主要特点：

该报告对全球妥布霉素眼药水市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模（百万美元）和年复合成长率（CAGR% ）。
它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数介绍了全球妥布霉素眼药水市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球妥布霉素眼药水市场迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球妥布霉素眼药水市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 9 章：竞争格局

公司简介
- AdvaCare Pharma
- Beye, LLC.
- Grevis Pharmaceuticals Pvt Ltd.
- Elvia Care Pvt Ltd
- Novalab Healthcare
- Zydus Group
- Bausch + Lomb
- Hilbert Healthcare
- Sanify Healthcare
- Choroid Laboratories Private Limited.
- Torainse Lifecare Pvt. Ltd.
- Divine Laboratories Private Limited
- Incepta Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Limited

第 10 章：分析师建议

命运之轮
分析师观点
连贯的机会图

第 11 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6923

Global tobramycin eye drop market is estimated to be valued at USD 1,018.9 Mn in 2024 and is expected to reach USD 2,573.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1,018.9 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	14.10%	2031 Value Projection:	US$ 2,573.2 Mn

Figure. Global Tobramycin Eye Drop Market Share (%), By Region 2024

Global Tobramycin Eye Drop Market - IMG1

Tobramycin eye drops are topical aminoglycoside antibiotics that are used for treating external eye infections caused by susceptible Gram-negative bacteria. These work by interfering with bacterial protein synthesis, thus, stopping the growth of harmful bacteria. The expanding prevalence of ocular infections globally due to increasing risk factors such as prolonged computer use, contact lens wear, eye surgeries, and others boosts demand for tobramycin eye drops

Market Dynamics:

Global tobramycin eye drop market has been witnessing growth due to factors such as rising prevalence of eye diseases, growing elderly population who are more prone to eye problems, increasing awareness about eye care. However, the market growth can be hindered due to factors such as side effects associated with long-term use of tobramycin eye drops like eye irritation, conjunctivitis, and others. Ongoing research and development for novel drug delivery methods and combination therapies using tobramycin offers lucrative opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global tobramycin eye drop market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global tobramycin eye drop market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study AdvaCare Pharma, Beye, LLC., Grevis Pharmaceuticals Pvt Ltd., Elvia Care Pvt Ltd, Novalab Healthcare, Zydus Group, Bausch + Lomb, Hilbert Healthcare, Sanify Healthcare, Choroid Laboratories Private Limited., Torainse Lifecare Pvt. Ltd., Divine Laboratories Private Limited, Incepta Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global tobramycin eye drop market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tobramycin eye drop market.

Detailed Segmentation-

By Type:
- Tobramycin and Dexamethasone Suspension
- Tobramycin Suspension
- Others Tobramycin Combinations
By Indication:
- Bacterial Eye Infections
- Keratitis
- Pre-/post-ocular Surgery Prophylaxis
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AdvaCare Pharma
- Beye, LLC.
- Grevis Pharmaceuticals Pvt Ltd.
- Elvia Care Pvt Ltd
- Novalab Healthcare
- Zydus Group
- Bausch + Lomb
- Hilbert Healthcare
- Sanify Healthcare
- Choroid Laboratories Private Limited.
- Torainse Lifecare Pvt. Ltd.
- Divine Laboratories Private Limited
- Incepta Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Tobramycin Eye Drop Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Tobramycin Eye Drop Market, By Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Tobramycin and Dexamethasone Suspension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Tobramycin Suspension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others Tobramycin Combinations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Tobramycin Eye Drop Market, By Indication, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Bacterial Eye Infections
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Keratitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Pre-/post-ocular Surgery Prophylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Tobramycin Eye Drop Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Tobramycin Eye Drop Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
North Africa
Central Africa
South Africa